Mesothelioma Hub is a trusted resource dedicated to supporting those affected by mesothelioma. Our team of medical and legal experts bring insightful, reliable, and recent information on mesothelioma healthcare, from survivor stories and medical breakthroughs to guidance on treatment options and connecting with specialists.
On September 17th, 2024, the Food and Drug Administration (FDA) approved Keytruda (pembrolizumab) as a first-line treatment for unresectable advanced or metastatic malignant pleural mesothelioma (MPM). Keytruda is an immunotherapy drug that helps the immune system recognize and kill cancer cells by blocking proteins in immune cells, making them [...]
A fatal disease, also known as a terminal illness, is a medical condition that is not curable and will likely cause the death of a patient. Mesothelioma is considered a fatal disease, meaning patients typically pass away from it. Although aggressive forms of cancer can have an average survival [...]
